A retrospective analysis: do bacterial culture and sensitivity data support empiric use of piperacillin-tazobactam and antipseudomonal fluoroquinolones in hospitalized patients?
作者信息
Pulkit Saxena, Burkhart Ryan V, Ainsworth Craig R
机构信息
William Beaumont Army Medical Center, El Paso, Texas.
出版信息
US Army Med Dep J. 2017 Jul-Sep(2-17):9-11.
PMID:28853113
Abstract
摘要
相似文献
1
2
[Bacteriuria in pregnancy and its prevention with ampicillin].[妊娠期菌尿及其用氨苄西林预防]
Munch Med Wochenschr. 1972 Nov 24;114(47):2085-6.
3
Heteroresistance to Piperacillin-Tazobactam in Clinical Isolates of Escherichia coli Sequence Type 131.大肠杆菌序列型131临床分离株对哌拉西林-他唑巴坦的异质性耐药
Antimicrob Agents Chemother. 2017 Dec 21;62(1). doi: 10.1128/AAC.01923-17. Print 2018 Jan.
4
[Osteomyelitis: germ-spectrum and resistance situation].
Arch Orthop Unfallchir. 1970;69(1):83-92. doi: 10.1007/BF00416061.
5
[Choice of antibiotics in infections of the urinary tract].[尿路感染中抗生素的选择]
Acta Urol Belg. 1971;39(4):533-7.
6
[Results of treatment with trimethoprim-sulfamethoxazole in nonspecific urinary tract infections in pediatric urology].[甲氧苄啶-磺胺甲恶唑治疗小儿泌尿外科非特异性尿路感染的结果]
Monatsschr Kinderheilkd (1902). 1972 Sep;120(9):346-9.
7
Clinical outcomes in patients with piperacillin/tazobactam-non-susceptible but ceftriaxone-susceptible E. coli or K. pneumoniae bloodstream infection.哌拉西林/他唑巴坦不敏感但头孢曲松敏感的大肠埃希菌或肺炎克雷伯菌血流感染患者的临床结局。
J Antimicrob Chemother. 2024 Jun 3;79(6):1456-1461. doi: 10.1093/jac/dkae134.
8
Antibiogram and molecular characterization of multi-drug resistant microorganisms isolated from urinary tract infections.从尿路感染中分离出的多重耐药微生物的抗菌谱及分子特征
Pak J Pharm Sci. 2021 May;34(3(Supplementary)):1111-1118.
9
The importance of underlying disease in patients with gram-negative bacteremia.潜在疾病在革兰氏阴性菌血症患者中的重要性。
Arch Intern Med. 1968 May;121(5):418-23.
10
[Comparative effectiveness of gentamycin and other antibiotics in experiment].[庆大霉素与其他抗生素在实验中的比较疗效]
Antibiotiki. 1969 Aug;14(8):716-21.
Zotero 插件